United States · 
Who invested in VelosBio?
VelosBio's investors include Decheng Capital, Takeda Digital Ventures, Chiesi Ventures, Arix Bioscience and Sofinnova Ventures/ Pappas.
United States · Series A startup
Who invested in VelosBio
Funding summaryUpdated 26 Oct 2026
$58Mraised across 1 round since 2018, from 1 source
- Latest round
- Series A, $58MSept 2018
- Investors
- 5
The rounds
- Sept 2018Series A$58M
Decheng Capital- Takeda Digital Ventures
Chiesi Ventures
Arix Bioscience- Sofinnova Ventures/ Pappas
Reported by FinSMEsSEC filing: $35M sold, first sale Sept 2018
Founders and team
From the SEC filings it signed: 4 on the team.
- Clayton KnoxExecutive Officeri
- David JohnsonExecutive Officer, Directori
- Langdon MillerExecutive Officeri
- Scott KarchmerExecutive Officeri
On the board, as filediAlan ColowickCam GallagherJayson PunwaniJonathan TobinKaran TakharMin Cui
Everyone who backed them
Takeda Digital VenturesCompany1round
Sofinnova Ventures/ Pappasno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list VelosBio as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about VelosBio
How much has VelosBio raised?
VelosBio has raised $58M across 1 round since 2018.
When did VelosBio last raise?
VelosBio's most recent round was a Series A of $58M in Sept 2018.
What was VelosBio's biggest round?
Its most recent round, $58M in Sept 2018, is also its largest on record.
Who backed VelosBio first?
VelosBio's first round on record, in Sept 2018, was backed by Decheng Capital, Takeda Digital Ventures and Chiesi Ventures and 2 others.
What stage is VelosBio at?
VelosBio's latest named round is a Series A, in Sept 2018.
Where is VelosBio based?
VelosBio is based in the United States.
Companies like VelosBio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.